For: | Fendrich V, Michl P, Habbe N, Bartsch DK. Liver-specific therapies for metastases of neuroendocrine pancreatic tumors. World J Hepatol 2010; 2(10): 367-373 [PMID: 21160945 DOI: 10.4254/wjh.v2.i10.367] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v2/i10/367.htm |
Number | Citing Articles |
1 |
Liangtao Ye, Huilin Ye, Quanbo Zhou, Zhihua Li, Qing Lin, Langping Tan, Wenchao Gao, Zhiqiang Fu, Shangyou Zheng, Rufu Chen. A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: New proposal for low- and high-grade groups, validation of a nomogram for prognosis, and novel follow-up strategy for liver metastases. International Journal of Surgery 2016; 29: 108 doi: 10.1016/j.ijsu.2016.03.036
|
2 |
Xavier M Keutgen, Bruna Babic, Naris Nilubol. Management of Pancreatic Neuroendocrine Tumors. International Journal of Endocrine Oncology 2016; 3(3): 267 doi: 10.2217/ije-2016-0002
|
3 |
Mark A. Lewis, Joleen Hubbard. Multimodal Liver-Directed Management of Neuroendocrine Hepatic Metastases. International Journal of Hepatology 2011; 2011: 1 doi: 10.4061/2011/452343
|
4 |
Thomas E. Clancy. Surgical Management of Pancreatic Neuroendocrine Tumors. Hematology/Oncology Clinics of North America 2016; 30(1): 103 doi: 10.1016/j.hoc.2015.09.004
|
5 |
Aksel Foss, Jan P. Lerut. Liver transplantation for metastatic liver malignancies. Current Opinion in Organ Transplantation 2014; 19(3): 235 doi: 10.1097/MOT.0000000000000086
|
6 |
Christian Geis, Volker Fendrich, Peter Rexin, Pietro Di Fazio, Detlef K. Bartsch, Matthias Ocker, Karl Quint, Anna E. Heverhagen. Ileal neuroendocrine tumors show elevated activation of mammalian target of rapamycin complex. Journal of Surgical Research 2015; 194(2): 388 doi: 10.1016/j.jss.2014.10.052
|
7 |
Robert T. Jensen, Guillaume Cadiot, Maria L. Brandi, Wouter W. de Herder, Gregory Kaltsas, Paul Komminoth, Jean-Yves Scoazec, Ramon Salazar, Alain Sauvanet, Reza Kianmanesh. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Functional Pancreatic Endocrine Tumor Syndromes. Neuroendocrinology 2012; 95(2): 98 doi: 10.1159/000335591
|
8 |
Mohammed Shaheen, Mazen Hassanain, Murad Aljiffry, Tatiana Cabrera, Prosanto Chaudhury, Eve Simoneau, Nuttawut Kongkaewpaisarn, Ayat Salman, Juan Rivera, Mohammad Jamal, Robert Lisbona, Azzam Khankan, David Valenti, Peter Metrakos. Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis. HPB 2012; 14(1): 60 doi: 10.1111/j.1477-2574.2011.00405.x
|
9 |
Ser Yee Lee, Peng Chung Cheow, Jin Yao Teo, London L. P. J. Ooi. Surgical Treatment of Neuroendocrine Liver Metastases. International Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/146590
|
10 |
Ryuichiro Doi. Determinants of surgical resection for pancreatic neuroendocrine tumors. Journal of Hepato-Biliary-Pancreatic Sciences 2015; 22(8): 610 doi: 10.1002/jhbp.224
|